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Immunoglobulins  are  first  synthesized  as  antigen  receptors  integrated  into  the 
plasma membrane of resting B cells, and, subsequently, as soluble receptors secreted 
by mature  plasma  cells.  Although  these  forms, when  derived from  a  single  B  cell 
clone, share variable (V) regions (1, 2), their heavy-chain constant  (CH) regions are 
otherwise functionally and  topologically distinct.  Recent investigations in both the 
human and  murine systems have demonstrated that  the heavy chain of membrane 
IgM ~m) and the heavy chain of secretory IgM (,us) are distinct from one another by 
a divergence in primary structure at the C  terminus (3-7). 
The predominance of IgA in external glandular secretions (8) has focused previous 
attention to the secretory heavy chain of this class. Two distinct  human subclasses 
have been identified  (9).  The major serum  form  (IgA1)  has been shown by amino 
acid-sequence  analysis  to  have  a  hinge  region  not  found  in  any  other  Ig  class, 
including IgA2 (10). As dimers in a complex with J chain (11), both subclasses interact 
with secretory component (12), and are thereby transported across glandular epithelia 
(13).  These  interactions,  as  well  as  the  circulatory patterns  and  differentiation of 
surface IgA  + B cells, have been reviewed in detail elsewhere (14). In contrast, little is 
known about the heavy chain of membrane IgA (am). 
To investigate whether structural differences might exist between am and the heavy 
chain  of secretory IgA  (as),  we  have  in  the  present  study  analyzed  the  primary 
translation products and in the vivo synthesized forms of the a  chain, derived from a 
human B lymphoblastoid cell line positive for both membrane and secretory IgA. 
Materials and Methods 
Most of the procedures used in this study have been detailed previously, among these are: 
the maintenance of lymphoblastoid cell lines (15); the preparation and characterization of anti- 
a chain antibodies (1); immunofluorescent staining for surface and intracellular immunoglob- 
ulins  (15); extraction of total  cellular  RNA  with  sodium  dodeeyl sulfate  (SDS)/phenol/ 
chloroform/isoamylalcohol and proteinase K (16); and the assay for ceil-free protein synthesis 
in a staphylococcal nuclease-treated wheat germ extract (17). 
For in vivo pulses with [3SS]methionine, cells (4 ×  106/ml) were first incubated for 2 h at 
37°C  in  methionine-free RPMI-1640 supplemented with  5% dialyzed agammaglobulinemic 
horse serum,  and then resuspended  at 5 ×  107/ml with 500 ~Ci/ml  [aSS]methionine for the 
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indicated  time  periods  (3-8  min).  Products labeled  during an  8-min  pulse  were  chased  in 
complete  RPMI-1640 medium supplemented  with 5% agammaglobulinemic horse serum at a 
cell concentration of 5 ×  105/ml. Cells and in vitro translation  products were prepared  for 
immunoprecipitation as described  elsewhere (3), except that sheep anti-human a  chain anti- 
bodies were used with protein A-Sepharose CL-4B at pH 8.3. 
Immunoprecipitates were washed and then divided for incubation in the presence or absence 
of endo-~-N-acetylglucosaminidase  H  (endo H). Each sample was resuspended  in 25 #1 of 1% 
SDS, 50 mM dithiothreitol  (DTT),  1 mM Tris-HC1 (pH 7.6), incubated for  10 min at 37°C 
and then for 3 min at  100°C, and transferred  to an equal vol of 0.3 M  Na citrate (pH 5.3) 
containing 5% Trasylol  and 0.5 #g/ml pepstatin.  I #1 of endo H  (3 #g/ml) was added to the 
indicated tubes, after which all tubes were incubated for 16 h at 37 °C. Before gel electrophoresis, 
samples were adjusted  directly  to 2.5% SDS, 20% sucrose, 0.008% bromphenol blue, 80 mM 
Tris-HCl (pH 7.0), and 50 mM DTT, reduced  for 30 min at 37°C, incubated at  100°C for 3 
min, and alkylated  in the presence of 250 mM iodoacetamide  for 30 rain at 37°C.  10% SDS- 
polyacrylamide slab gels were run at 25 mA, constant current, for 24 h, and then processed for 
fluorography (18). 
Endo H  was the kind gift of Dr.  P. W.  Robbins,  Massachusetts  Institutes  of Technology. 
Wheat germ was obtained from General Mills, Inc., Minneapolis,  Minn.; [aSS]methionine (700 
Ci/mmol) from New England Nuclear, Boston, Mass.; RPMI-1640 medium from Microbiolog- 
ical Associates Bioproducts, Walkersville, Md.; agammaglobulinemic horse serum from Grand 
Island Biological Co., Grand Island,  N. Y.; protein  A-Sepharose CL-4B from Pharmacia Fine 
Chemicals, Inc., Uppsala,  Sweden; and Trasylol from FBA Pharmaceuticals,  Inc., New York. 
Results and Discussion 
The synthesis of the IgA heavy chain (a chain) was initially studied in two types of 
cells, which were chosen by fluorescence for their differential expression of membrane 
and intracellular  (secretory)  IgA: 32a.1, a  human Epstein-Barr virus-transformed B 
lymphoblastoid cell line, made both forms of IgA; plasma cells from patient Va with 
IgA multiple myeloma, exhibited predominantly intraeellular staining. Each cell type 
was pulsed  in  vivo for 8  min, with  [~S]methionine,  lysed in  1% Triton X-100, and 
immunoprecipitated  with  affinity-purified  sheep  anti-human  a  chain  antibodies. 
SDS-polyacrylamide gel electrophoresis  (PAGE) of reduced and alkylated immuno- 
precipitates  demonstrated  that  32a. 1 cells synthesized three  discrete forms of the a 
chain (Fig.  1, lane A4). When precipitates of Va plasma cells were run on SDS-PAGE, 
two forms of the a  chain were  found: a  dominant  band migrating near the  upper 
band of the 32a. 1 forms and a  minor band with a  slightly faster mobility (data not 
shown). These results were suggestive of structural differences between am and as. 
However,  the  distinction  between  O~m  and  a8  may be  a  result  of a  difference  in 
polypeptide structure  and/or in  post-translational  processing. To resolve this,  total 
cellular RNA was prepared from the cell line 32a. 1 and translated in vitro in a wheat 
germ cell-free  system.  Under  these  conditions,  polypeptide  chains  are  synthesized 
without  modifications.  The  [SSS]methionine-labeled  primary  translation  products 
were immunoprecipitated with sheep anti-human a  chain antibodies, in the presence 
or absence of SDS-denatured human IgA, and were then resolved on SDS-PAGE. In 
32a. 1, two discrete primary translation products of the a  chain were immunoprecip- 
itated  (Fig.  1,  lane A1);  the  precipitation of each was inhibited  by the addition of 
cold IgA (data not shown). If these two forms of the a  chain are analogous to the two 
in vitro translated forms of# chain (3, 5, 6), they might be pre-am and pre-a~,  and the 
difference in molecular weight between them must reside in the primary structure of 
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Fxa.  1.  Resolution of two ot chains, which were synthesized in vitro, and of pulse-chased a chain 
intermediates, which were synthesized in vivo. Lane  1: translation products of 32a.1, immunopre- 
cipitated with sheep anti-a chain. Lanes 2-7: a chain intermediates from 32a.1, pulsed in vivo for 
3 rain (lane 2), 5 rain (lane 3), 8 min (lane 4) with [anSlmethionine, or chased, after an 8-rain pulse, 
for 1 h (lane 5), 3 h (lane 6) or 10 h (lane 7). (B) Endo H treatment of products synthesized in vivo. 
Lanes 2-7 represent samples equivalent to those described in (A) treated with endo H. Lane B1 is 
the same as lane A1. All tracks of (A) and (B) were aligned from the same fluorographed gel. 
Further  experiments  were carried  out  in  vivo.  Cells  from 32a. 1 were pulsed  with 
[35S]methionine for 3, 5, or 8  min to identify the earliest  in vivo synthesized forms of 
the a  chain  (Fig.  1 A,  lanes  2-4).  In addition,  cells were pulsed  for 8  min and  then 
chased  in  medium  containing  cold  methionine  for  1,  3,  or  10  h  to  analyze  later 
biosynthetic forms (Fig.  1 A, lanes 5-7). When anti-a chain immunoprecipitates were 
resolved by 10% SDS-PAGE (Fig.  1 A), it was found that after a  3-min pulse, only two 
labeled forms of the a  chain resolved (lane A2). This was also the case when cells were 
pulsed for 5 min (lane A3). However, after an 8-min pulse, three discrete species were 
present  (lane A4). These three forms of the a  chain remained associated with the cell 
pellet  for chase periods of up to 3 h  (lanes A5 and A6).  By  10 h  (lane A7), only one 
form was detectable. The relative mobility of the two primary translation products of 
a chain is shown for comparison (lane A 1). The results of  these pulse-chase experiments 
indicated  that  the early biosynthetic forms of a  chain consist of two chains  that  are 
subsequently modified to yield three. 
Posttranslational  proteolysis, as well as modifications of N- or O-linked oligosaccha- 
rides, might have been the basis for this apparent conversion. To discriminate between 
these possibilities,  each of the above immunoprecipitates  was digested with endo H. 
Remaining after such treatment  would be polypeptide chains stripped of sensitive N- 
linked oligosaccharides, with any O-linked oligosaccharides left intact (19). The results 
are shown in Fig.  1 B. The relative mobilities of the primary translation products were 
not  affected  by this  treatment  and  are  included  for comparison  (lane  A1  and  lane 
B1).  It was found that,  at  all pulse and chase periods up to 3 h, the intermediates  of 
a  chain synthesis in vivo were reduced to a doublet. This doublet had a faster mobility 
than  their  untreated  counterparts,  which  is consistent  with  the removal of N-linked 
oligosaccharides,  as  well  as  a  faster  mobility  than  the  two  primary  translation 
products, which is consistent with the removal in vivo of a signal peptide. The relative 
mobility of this doublet was the same after a  3-min pulse (lane B2), when two a  chain 
intermediates were present  (lane A2), as it was after a  3-h chase (lane B6), when three McCUNE ET AL.  BRIEF  DEFINITIVE REPORT  I687 
a  chain intermediates were present  (lane A6). This comparison of the a  chain forms 
in the presence or absence of endo H  treatment demonstrates that the three forms of 
a  chain do not arise as a  function  of post-translational  proteolysis; otherwise, three 
forms of a  chain would be generated by endo H  treatment. Nor are they generated as 
a consequence of detectable O-glycosylation; otherwise, at longer chase periods, endo 
H  treatment  would  have  shifted  the  a  chain  forms to  a  doublet  with  a  different 
mobility than that found at earlier pulse periods (20).  It appears, instead, that these 
three forms represent two different a  chain polypeptide chains with endo H-sensitive 
oligosaccharides of varying compositions. The data would suggest that the lower band 
of the earliest biosynthetic forms (lanes A2 and A3) chased to the band of intermediate 
mobility at later time points (lanes A4-6). It is not clear what type of modification of 
an N-linked oligosaccharide would produce such a shift in relative mobility. 
After a  10-h  chase,  the  major cell-associated  form of the  a  chain  (lane A7)  was 
reduced by endo H  treatment to a  single band, comigrating with the lower band of 
the doublets in panel B  (lane B7). The presence of only one band indicates that the 
two a  chain  intermediates  differ not  only in  molecular weight,  but  in  intracellular 
turnover rate. The finding that this band was the lower molecular weight form of the 
endo H-treated intermediates was unexpected. Its slow turnover rate is consistent with 
that of a membrane, as opposed to a secretory, protein; in this case, am would appear 
to be of a  lower molecular weight than as. The predominance in Va plasma cells of 
a  higher  molecular  weight  form would  support  this  interpretation.  However,  this 
experiment does not rule out the possibility that this form in fact represents as; in this 
case, am would appear to have a faster turnover rate than as. Either possibility would 
differ from observations with #m and  8m  (the heavy chain  of membrane IgD).  For 
each of these Ig heavy chain classes, the membrane chains have a  higher molecular 
weight and a slower turnover rate than the corresponding secretory chains,/~ and 6s 
(the heavy chain of secretory IgD; 3, 21). 
This study indicates that am and as are distinct from one another on the basis of a 
difference in molecular weight, both in vitro as primary translation products and as 
intermediates  of in  vivo biosynthesis.  This  difference  is  most  likely  reflective of a 
difference in amino acid sequence of the respective a  chains. An analogous situation 
has  been  observed with  other  immunoglobulin  heavy chain  classes.  #m  and ~  are 
distinguished  from one  another  by different  C-terminus  tails  (3-7);  8m and  ~  are 
likewise  encoded  as  distinct  polypeptide chains  (21).  The  C-terminal  tail  of a~  is 
similar to that of/~, in both amino acid sequence  (22)  and in the ability to bind J 
chain (11). It is probable that am possesses, like #m, a  different C-terminal tail that is 
hydrophobic in  nature and necessary for membrane integration.  These different C- 
termini  might be generated as a  result of differential processing of a  single nuclear 
RNA transcript,  as seems to be the case for #m,/~, ~$m and 8~. It is likely that  these 
analogies extend to all immunoglobulin heavy chain classes. 
Some processing events appear, however, to be class specific. The finding that the 
a chain of lowest molecular weight has the slowest intracellular turnover rate is clearly 
different from the results for # or ~ chains. This finding may be reflective of a second 
point of variance between the polypeptide chains of am and as or, alternatively, of a 
post-translational processing event unique for a chain. Further analysis of these chains 
will be informative on this point. 1688  McCUNE ET  AL.  BRIEF  DEFINITIVE REPORT 
Summary 
Structural differences between am (the heavy chain of membrane IgA) and a8 (the 
heavy chain of secretory IgA) were investigated. Messenger RNA from the human B 
lymphoblastoid line 32a. 1, expressing both membrane and secretory IgA, was trans- 
lated  in  a  wheat  germ  cell-free  system,  resulting  in  the  synthesis  of two  primary 
translation products for the a  chain, that differed in molecular weight. In vivo pulse 
and pulse-chase experiments demonstrated that  two early biosynthetic forms of the 
a  chain were subsequently modified to yield three intracellular forms. As shown by 
endo-fl-N-acetylglucosaminidase H  (endo H)  treatment, these forms represent two c~ 
polypeptide chains,  with  varying compositions of N-linked oligosaccharides.  Of the 
two forms of the a  chain remaining after endo H  treatment, only the form with the 
lowest  molecular  weight  was  associated  with  cells  after  long  chase  periods.  The 
possible significance of this difference from the results with/~ and 8 chains is discussed. 
These  results  indicate  that  am  is  distinguished  fromn  a8  by  a  difference  in  both 
primary structure  and intracellular  processing. The functional  consequences  of this 
distinction,  previously shown for the heavy chain of membrane IgM (#m)  and heavy 
chain  of secretory IgM  (/~),  may reflect  a  principle  common to  the secretory and 
membrane forms of all immunoglobulin heavy chain classes. 
We thank Ms. L. Light for her expert preparation of this manuscript. 
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